BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19553356)

  • 1. Rank-based estimation in the {ell}1-regularized partly linear model for censored outcomes with application to integrated analyses of clinical predictors and gene expression data.
    Johnson BA
    Biostatistics; 2009 Oct; 10(4):659-66. PubMed ID: 19553356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covariate dimension reduction for survival data via the Gaussian process latent variable model.
    Barrett JE; Coolen AC
    Stat Med; 2016 Apr; 35(8):1340-53. PubMed ID: 26526057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial least squares dimension reduction for microarray gene expression data with a censored response.
    Nguyen DV
    Math Biosci; 2005 Jan; 193(1):119-37. PubMed ID: 15681279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the prognostic value of survival models with application to gene expression signatures.
    Hielscher T; Zucknick M; Werft W; Benner A
    Stat Med; 2010 Mar; 29(7-8):818-29. PubMed ID: 20213714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosting method for nonlinear transformation models with censored survival data.
    Lu W; Li L
    Biostatistics; 2008 Oct; 9(4):658-67. PubMed ID: 18344565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The additive hazards model with high-dimensional regressors.
    Martinussen T; Scheike TH
    Lifetime Data Anal; 2009 Sep; 15(3):330-42. PubMed ID: 19184421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kernel Cox regression models for linking gene expression profiles to censored survival data.
    Li H; Luan Y
    Pac Symp Biocomput; 2003; ():65-76. PubMed ID: 12603018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Prediction for Prostate Cancer Recurrence Through Regularized Estimation with Simultaneous Adjustment for Nonlinear Clinical Effects.
    Long Q; Chung M; Moreno CS; Johnson BA
    Ann Appl Stat; 2011 Sep; 5(3):2003-2023. PubMed ID: 22081781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sparse partial least squares classification for high dimensional data.
    Chung D; Keles S
    Stat Appl Genet Mol Biol; 2010; 9(1):Article17. PubMed ID: 20361856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On optimal treatment regimes selection for mean survival time.
    Geng Y; Zhang HH; Lu W
    Stat Med; 2015 Mar; 34(7):1169-84. PubMed ID: 25515005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the Plackett distribution with bivariate censored data.
    Ghosh D
    Int J Biostat; 2008; 4(1):Article 7. PubMed ID: 22462114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial neural network for the joint modelling of discrete cause-specific hazards.
    Biganzoli EM; Boracchi P; Ambrogi F; Marubini E
    Artif Intell Med; 2006 Jun; 37(2):119-30. PubMed ID: 16730963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and LASSO.
    Datta S; Le-Rademacher J; Datta S
    Biometrics; 2007 Mar; 63(1):259-71. PubMed ID: 17447952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A framework for list representation, enabling list stabilization through incorporation of gene exchangeabilities.
    Soneson C; Fontes M
    Biostatistics; 2012 Jan; 13(1):129-41. PubMed ID: 21908866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instrumental variable additive hazards models.
    Li J; Fine J; Brookhart A
    Biometrics; 2015 Mar; 71(1):122-130. PubMed ID: 25298257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of partially linear structure in additive models with an application to gene expression prediction from sequences.
    Lian H; Chen X; Yang JY
    Biometrics; 2012 Jun; 68(2):437-45. PubMed ID: 21950383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified F-test for hypothesis testing in large-scale data.
    Salehi M; Mohammadpour A; Mohammadi M; Aminghafari M
    J Biopharm Stat; 2018; 28(6):1078-1089. PubMed ID: 29431596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regularized estimation in the accelerated failure time model with high-dimensional covariates.
    Huang J; Ma S; Xie H
    Biometrics; 2006 Sep; 62(3):813-20. PubMed ID: 16984324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimension reduction of microarray gene expression data: the accelerated failure time model.
    Nguyen TS; Rojo J
    J Bioinform Comput Biol; 2009 Dec; 7(6):939-54. PubMed ID: 20014472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model evaluation based on the negative predictive value for interval-censored survival outcomes.
    Han S; Tsui KW; Andrei AC
    Stat Methods Med Res; 2017 Apr; 26(2):661-673. PubMed ID: 25305195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.